blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2049474

EP2049474 - HEPATITIS C VIRUS INHIBITORS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  09.09.2016
Database last updated on 13.07.2024
Most recent event   Tooltip17.08.2018Lapse of the patent in a contracting state
New state(s): BG		published on 19.09.2018  [2018/38]
Applicant(s)For all designated states
Bristol-Myers Squibb Company
Route 206 and Province Line Road
Princeton, NJ 08543 / US
[2015/45]
Former [2009/17]For all designated states
Bristol-Myers Squibb Company
Route 206 and Province Line Road P.O. Box 4000
Princeton NJ 08543-4000 / US
Inventor(s)01 / SCOLA, Paul Michael
c/o Bristol-Myers Squibb Company
5 Research Parkway
Wallingford, CT 06492 / US
02 / SUN, Li-Qiang
c/o Bristol-Myers Squibb Company
5 Research Parkway
Wallingford, CT 06492 / US
 [2015/45]
Former [2009/17]01 / SCOLA, Paul Michael
c/o Bristol-Myers Squibb Company 5 Research Parkway
Wallingford, CT 06492 / US
02 / SUN, Li-Qiang
c/o Bristol-Myers Squibb Company 5 Research Parkway
Wallingford, CT 06492 / US
Representative(s)Reitstötter Kinzebach
Patentanwälte
Sternwartstraße 4
81679 München / DE
[N/P]
Former [2015/45]Reitstötter Kinzebach
Patentanwälte
Sternwartstrasse 4
81679 München / DE
Former [2009/17]Reitstötter - Kinzebach
Patentanwälte Sternwartstrasse 4
81679 München / DE
Application number, filing date07799446.510.07.2007
[2009/17]
WO2007US73149
Priority number, dateUS20060819903P11.07.2006         Original published format: US 819903 P
[2009/17]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2008008776
Date:17.01.2008
Language:EN
[2008/03]
Type: A2 Application without search report 
No.:EP2049474
Date:22.04.2009
Language:EN
The application published by WIPO in one of the EPO official languages on 17.01.2008 takes the place of the publication of the European patent application.
[2009/17]
Type: B1 Patent specification 
No.:EP2049474
Date:04.11.2015
Language:EN
[2015/45]
Search report(s)International search report - published on:EP03.04.2008
ClassificationIPC:C07D207/16
[2009/17]
CPC:
C07D207/16 (EP,US); A61P31/14 (EP); A61P43/00 (EP);
C07D401/12 (EP,US); C07D405/12 (EP,US); C07D409/12 (EP,US);
C07K5/0808 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2015/45]
Former [2009/17]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MT,  NL,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
TitleGerman:HEMMER DES HEPATITIS-C-VIRUS[2009/17]
English:HEPATITIS C VIRUS INHIBITORS[2009/17]
French:INHIBITEURS DU VIRUS DE L'HÉPATITE C[2009/17]
Entry into regional phase05.01.2009National basic fee paid 
05.01.2009Designation fee(s) paid 
05.01.2009Examination fee paid 
Examination procedure05.01.2009Examination requested  [2009/17]
27.01.2012Despatch of a communication from the examining division (Time limit: M06)
21.06.2012Reply to a communication from the examining division
10.04.2014Despatch of a communication from the examining division (Time limit: M04)
24.07.2014Reply to a communication from the examining division
13.05.2015Communication of intention to grant the patent
23.09.2015Fee for grant paid
23.09.2015Fee for publishing/printing paid
23.09.2015Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  27.01.2012
Opposition(s)05.08.2016No opposition filed within time limit [2016/41]
Fees paidRenewal fee
10.07.2009Renewal fee patent year 03
14.07.2010Renewal fee patent year 04
12.07.2011Renewal fee patent year 05
13.07.2012Renewal fee patent year 06
10.07.2013Renewal fee patent year 07
14.07.2014Renewal fee patent year 08
10.07.2015Renewal fee patent year 09
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU10.07.2007
AT04.11.2015
BE04.11.2015
BG04.11.2015
CY04.11.2015
CZ04.11.2015
DK04.11.2015
EE04.11.2015
ES04.11.2015
FI04.11.2015
IT04.11.2015
LT04.11.2015
LV04.11.2015
MC04.11.2015
NL04.11.2015
PL04.11.2015
RO04.11.2015
SE04.11.2015
SI04.11.2015
SK04.11.2015
TR04.11.2015
GR05.02.2016
IS04.03.2016
PT04.03.2016
IE10.07.2016
LU10.07.2016
CH31.07.2016
LI31.07.2016
MT31.07.2016
[2018/38]
Former [2018/33]HU10.07.2007
AT04.11.2015
BE04.11.2015
CY04.11.2015
CZ04.11.2015
DK04.11.2015
EE04.11.2015
ES04.11.2015
FI04.11.2015
IT04.11.2015
LT04.11.2015
LV04.11.2015
MC04.11.2015
NL04.11.2015
PL04.11.2015
RO04.11.2015
SE04.11.2015
SI04.11.2015
SK04.11.2015
TR04.11.2015
GR05.02.2016
IS04.03.2016
PT04.03.2016
IE10.07.2016
LU10.07.2016
CH31.07.2016
LI31.07.2016
MT31.07.2016
Former [2018/29]HU10.07.2007
AT04.11.2015
BE04.11.2015
CY04.11.2015
CZ04.11.2015
DK04.11.2015
EE04.11.2015
ES04.11.2015
FI04.11.2015
IT04.11.2015
LT04.11.2015
LV04.11.2015
MC04.11.2015
NL04.11.2015
PL04.11.2015
RO04.11.2015
SE04.11.2015
SI04.11.2015
SK04.11.2015
TR04.11.2015
GR05.02.2016
IS04.03.2016
PT04.03.2016
IE10.07.2016
LU10.07.2016
CH31.07.2016
LI31.07.2016
Former [2018/28]HU10.07.2007
AT04.11.2015
BE04.11.2015
CY04.11.2015
CZ04.11.2015
DK04.11.2015
EE04.11.2015
ES04.11.2015
FI04.11.2015
IT04.11.2015
LT04.11.2015
LV04.11.2015
MC04.11.2015
NL04.11.2015
PL04.11.2015
RO04.11.2015
SE04.11.2015
SI04.11.2015
SK04.11.2015
GR05.02.2016
IS04.03.2016
PT04.03.2016
IE10.07.2016
LU10.07.2016
CH31.07.2016
LI31.07.2016
Former [2017/41]AT04.11.2015
BE04.11.2015
CZ04.11.2015
DK04.11.2015
EE04.11.2015
ES04.11.2015
FI04.11.2015
IT04.11.2015
LT04.11.2015
LV04.11.2015
MC04.11.2015
NL04.11.2015
PL04.11.2015
RO04.11.2015
SE04.11.2015
SI04.11.2015
SK04.11.2015
GR05.02.2016
IS04.03.2016
PT04.03.2016
IE10.07.2016
LU10.07.2016
CH31.07.2016
LI31.07.2016
Former [2017/22]AT04.11.2015
BE04.11.2015
CZ04.11.2015
DK04.11.2015
EE04.11.2015
ES04.11.2015
FI04.11.2015
IT04.11.2015
LT04.11.2015
LV04.11.2015
MC04.11.2015
NL04.11.2015
PL04.11.2015
RO04.11.2015
SE04.11.2015
SI04.11.2015
SK04.11.2015
GR05.02.2016
IS04.03.2016
PT04.03.2016
CH31.07.2016
LI31.07.2016
Former [2017/03]AT04.11.2015
BE04.11.2015
CZ04.11.2015
DK04.11.2015
EE04.11.2015
ES04.11.2015
FI04.11.2015
IT04.11.2015
LT04.11.2015
LV04.11.2015
NL04.11.2015
PL04.11.2015
RO04.11.2015
SE04.11.2015
SI04.11.2015
SK04.11.2015
GR05.02.2016
IS04.03.2016
PT04.03.2016
Former [2016/49]AT04.11.2015
CZ04.11.2015
DK04.11.2015
EE04.11.2015
ES04.11.2015
FI04.11.2015
IT04.11.2015
LT04.11.2015
LV04.11.2015
NL04.11.2015
PL04.11.2015
RO04.11.2015
SE04.11.2015
SI04.11.2015
SK04.11.2015
GR05.02.2016
IS04.03.2016
PT04.03.2016
Former [2016/39]AT04.11.2015
CZ04.11.2015
DK04.11.2015
EE04.11.2015
ES04.11.2015
FI04.11.2015
IT04.11.2015
LT04.11.2015
LV04.11.2015
NL04.11.2015
PL04.11.2015
RO04.11.2015
SE04.11.2015
SK04.11.2015
GR05.02.2016
IS04.03.2016
PT04.03.2016
Former [2016/36]AT04.11.2015
CZ04.11.2015
EE04.11.2015
ES04.11.2015
FI04.11.2015
IT04.11.2015
LT04.11.2015
LV04.11.2015
NL04.11.2015
PL04.11.2015
RO04.11.2015
SE04.11.2015
SK04.11.2015
GR05.02.2016
IS04.03.2016
PT04.03.2016
Former [2016/34]AT04.11.2015
CZ04.11.2015
ES04.11.2015
FI04.11.2015
IT04.11.2015
LT04.11.2015
LV04.11.2015
NL04.11.2015
PL04.11.2015
SE04.11.2015
GR05.02.2016
IS04.03.2016
PT04.03.2016
Former [2016/25]AT04.11.2015
ES04.11.2015
FI04.11.2015
IT04.11.2015
LT04.11.2015
LV04.11.2015
NL04.11.2015
PL04.11.2015
SE04.11.2015
GR05.02.2016
IS04.03.2016
PT04.03.2016
Former [2016/24]AT04.11.2015
ES04.11.2015
FI04.11.2015
IT04.11.2015
LT04.11.2015
NL04.11.2015
PL04.11.2015
SE04.11.2015
GR05.02.2016
IS04.03.2016
PT04.03.2016
Former [2016/23]ES04.11.2015
IT04.11.2015
LT04.11.2015
NL04.11.2015
SE04.11.2015
IS04.03.2016
Former [2016/22]ES04.11.2015
IT04.11.2015
LT04.11.2015
NL04.11.2015
IS04.03.2016
Former [2016/21]ES04.11.2015
IT04.11.2015
LT04.11.2015
Former [2016/20]ES04.11.2015
LT04.11.2015
Cited inInternational search[Y]US2003187018  (LLINAS-BRUNET MONTSE [CA], et al) [Y] 1-22 * examples 1-8; claim -; table 1 *;
 [XY]US2004048802  (RIPKA AMY [US], et al) [XY] 1-22 * page 22, compound 4; page 71, right-hand column, formulae; page 72, left-hand column, first formula; page 73, formulae;;; claims 1,25,30-40 *;
 [Y]WO2006020276  (GILEAD SCIENCES INC [US], et al) [Y] 1-22 * claims 29,41-46,49 *;
 [PX]WO2006086381  (BRISTOL MYERS SQUIBB CO [US], et al) [PX] 1,3,10-22* claims 1,3-5,11,13-26 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.